K.C. Pharmaceuticals, Inc FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection OAI · Feb 13, 2026
  • Last warning letter 2026
Inspections 11 4 OAI
Recalls 23 0 Class I (0%)
Warning letters 3 Latest Aug 12, 2026
510(k) clearances 0 None on file

K.C. Pharmaceuticals, Inc has 23 FDA recalls, 11 inspections, 0 510(k) clearances and 3 compliance actions on record. FDA has issued 3 warning letters to K.C. Pharmaceuticals, Inc, the most recent on Aug 12, 2026.

What these totals cover: FDA records filed under the name "K.C. Pharmaceuticals, Inc" and its spelling variants "K.C. Pharmaceuticals", "K C Pharmaceuticals".

Latest recall
D-0006-2027 · Class II · Sep 11, 2026
Latest inspection
Feb 13, 2026 · OAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls23Nov 15, 2026File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections11Nov 17, 2026Newest record Nov 9, 2026Current
Compliance actions3Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

K.C. Pharmaceuticals, Inc's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

K.C. Pharmaceuticals, Inc: FDA inspections per year

2017: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2018: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2019: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2020: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2022: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2023: 1 inspection (1 OAI), 1 warning letter, 2 recall records (0 Class I) 2024: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2025: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2026: 1 inspection (1 OAI), 1 warning letter, 16 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
2026111160
202500000
202410000
202311120
202200000
202100000
202010000
201900000
201800000
201710000

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing K.C. Pharmaceuticals, Inc as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check K.C. Pharmaceuticals, Inc yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

K.C. Pharmaceuticals, Inc FDA Warning Letters

3 warning letters from May 21, 2010 to Aug 12, 2026.

IssuedSubjectIssuing officeClose-out letter
Aug 12, 2026 · Letter on fda.gov CGMP/Finished Pharmaceuticals/AdulteratedCenter for Drug Evaluation and Research (CDER)
Aug 3, 2023 · Letter on fda.gov CGMP/Finished Pharmaceuticals/AdulteratedDivision of Pharmaceutical Quality Operations IV
May 21, 2010 · Record page

A warning letter is FDA's formal notice that a company has violated FDA requirements. Each date links to the letter on fda.gov where FDA has it online. Search the text of every letter with the FDA warning letter search.

Recent recalls

23 recall records from Mar 1, 2010 to Sep 11, 2026. Showing the 20 most recent. View all 23 recall records

NumberClassProductDate
D-0006-2027Class IISterile Lubricant Dry Eye Relief Eye Drops, 0.5 FL OZ (15 mL); a) LEADER, DISTRIBUTED BY CARDINAL…Sep 11, 2026
D-0004-2027Class IISterile EYE DROPS Advanced Relief, (dextran 70, 0.1%, polyethylene glycol 400 1% and…Sep 11, 2026
D-0008-2027Class IISterile Eye Drops Redness Relief (Glycerin 0.25%, Naphazoline HCl 0.02% Lubricant | Redness…Sep 11, 2026
D-0009-2027Class IISterile High Performance Ultra Lubricating Eye Drops (Polyethylene Glycol 400, 0.4% Relieves Dry…Sep 11, 2026
D-0002-2027Class IIArtificial Tears Sterile Lubricant Eye Drops (polyvinyl alcohol 0.5%, povidone 0.6%), 0.5 FL OZ (15…Sep 11, 2026
D-0003-2027Class IISterile EYE DROPS AC (tetrahydrozoline HCl 0.05%, zinc sulfate 0.25%), 0.5 fl. oz. (15 mL) bottles…Sep 11, 2026
D-0007-2027Class IISterile Eye Drops, ORIGINAL, Tetrahydrozoline HCl 0.05% Redness Reliever ¿ Fast Acting Formula)…Sep 11, 2026
D-0005-2027Class IIEye Drops MAXIMUM, REDNESS RELIEF, Sterile, 1/2 FL OZ (0.5 ML); a) exchange select, Manufactured for…Sep 11, 2026
D-0412-2026Class IIUltra Lubricating Eye Drops (polyethylene 400 0.4%, propylene glycol 0.3%), Sterile, 0.5 FL OZ…Mar 3, 2026
D-0415-2026Class IISTERILE EYE DROPS SOOTHING TEARS (polyethylene glycol 400 0.4% and propylene glycol 0.3%), 0.5 OZ…Mar 3, 2026
D-0413-2026Class IISterile Eye Drops ORIGINAL FORMULA (tetrahydrozoline HCl 0.05%), 0.5 FL OZ (15mL) bottles; a) Good…Mar 3, 2026
D-0410-2026Class IIEYE DROPS Advanced Relief, (dextran 70 0.1%, polyethylene glycol 400 1% and tetrahydrozoline HCl…Mar 3, 2026
D-0411-2026Class IIDry Eye Relief Eye Drops, (glycerin 0.2%, hypromellose 0.2% and polyethylene glycol 400 1%) 0.5 FL…Mar 3, 2026
D-0409-2026Class IISterile EYE DROPS AC (tetrahydrozoline HCl 0.05%, zinc sulfate 0.25%), 0.5 fl. oz. (15 mL) bottles…Mar 3, 2026
D-0416-2026Class IIArtificial Tears Sterile Lubricant Eye Drops (polyvinyl alcohol 0.5%, povidone 0.6%), 0.5 FL OZ (15…Mar 3, 2026
D-0414-2026Class IISterile EYE DROPS REDNESS LUBRICANT (glycerin 0.25% and naphazoline HCl 0.012%), 0.5 fl oz (15 mL)…Mar 3, 2026
D-0898-2023Class IIDry Eye Relief Lubricant Eye Drops, (Glycerin 0.2%, Hypromellose 0.2 %, Polyethylene glycol 400 1%)…Jun 13, 2023
D-0897-2023Class IIOriginal Eye Drops; Redness Reliever; (Tetrahydrozoline HCl), 0.05%, 0.5 FL OZ (15mL); distributed…Jun 13, 2023
D-0322-2015Class IIIEye Drops Industrial Strength (Polyethylene glycol 400 1%, Tetrahydrozoline HCl 0.05%), 0.5 FL OZ…Dec 4, 2014
D-0320-2015Class IIIEye Drops (Tetrahydrozoline HCl 0.05%), 0.5 FL OZ (15 mL) Bottles, Over the Counter. Labeled: a)…Dec 4, 2014

Recent FDA inspections

11 inspections from Dec 30, 2009 to Feb 13, 2026.

DateSiteProductClassificationFEI
Feb 13, 2026Pomona, CADrugsOfficial Action Indicated (OAI)2026940
Aug 28, 2024Pomona, CADrugsVoluntary Action Indicated (VAI)2026940
Feb 13, 2023Pomona, CADrugsOfficial Action Indicated (OAI)2026940
Jan 30, 2020Pomona, CADrugsVoluntary Action Indicated (VAI)2026940
Nov 16, 2017Pomona, CADrugsVoluntary Action Indicated (VAI)2026940
Mar 19, 2015Pomona, CADrugsVoluntary Action Indicated (VAI)2026940
May 23, 2014Pomona, CADevicesNo Action Indicated (NAI)2026940
Jun 10, 2013Pomona, CADrugsOfficial Action Indicated (OAI)2026940
Aug 1, 2012Pomona, CADevicesVoluntary Action Indicated (VAI)2026940
Feb 14, 2011Pomona, CADevicesVoluntary Action Indicated (VAI)2026940
Dec 30, 2009Pomona, CADevicesOfficial Action Indicated (OAI)2026940
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

Compliance Actions

FDA's compliance actions data lists 3 compliance actions under K.C. Pharmaceuticals, Inc: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.

Most recent: Warning Letter, Aug 12, 2026.

The warning letters in this data are listed above, together with the letters FDA posts online; a letter found in both is shown once. Other actions are not listed on this page. Search them with the FDA warning letter search or browse all compliance actions.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 2026940Pomona, CA11Feb 13, 2026

K.C. Pharmaceuticals, Inc and the FDA: common questions

Has K.C. Pharmaceuticals, Inc received an FDA warning letter?

Yes. FDA has issued 3 warning letters to K.C. Pharmaceuticals, Inc. The most recent is dated Aug 12, 2026, with the subject "CGMP/Finished Pharmaceuticals/Adulterated".

Has K.C. Pharmaceuticals, Inc received an FDA Form 483?

FDA has not published a Form 483 for "K.C. Pharmaceuticals, Inc" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect K.C. Pharmaceuticals, Inc?

The most recent FDA inspection on file ended Feb 13, 2026 at Pomona, CA and was classified OAI. FDA has 11 inspections of K.C. Pharmaceuticals, Inc on file, 4 of them classified OAI (official action indicated).

Has K.C. Pharmaceuticals, Inc had an FDA recall?

Yes. K.C. Pharmaceuticals, Inc has 23 FDA recalls on record. The most recent started Sep 11, 2026.

Need more than this page shows? Ask about K.C. Pharmaceuticals, Inc in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.